Literature DB >> 26173451

Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma.

S Maeda1, K Ohno2, A Fujiwara-Igarashi3, K Uchida4, H Tsujimoto1.   

Abstract

Although regulatory T cells (Tregs) play an integral role in immunologic tolerance and the maintenance of intestinal homeostasis, their involvement in canine gastrointestinal diseases, including idiopathic inflammatory bowel disease (IBD) and intestinal lymphoma, remains unclear. Here we show altered numbers of forkhead box P3 (Foxp3)-positive Tregs in the intestine of dogs with IBD and intestinal lymphoma. IBD was diagnosed in 48 dogs; small cell intestinal lymphoma was diagnosed in 46 dogs; large cell intestinal lymphoma was diagnosed in 30 dogs; and 25 healthy beagles were used as normal controls. Foxp3-positive Tregs in the duodenal mucosa were examined by immunohistochemistry and immunofluorescence. Duodenal expression of interleukin-10 mRNA was quantified by real-time reverse transcription polymerase chain reaction. The number of Foxp3-positive lamina propria cells and the expression of interleukin-10 mRNA were significantly lower in dogs with IBD than in healthy dogs and dogs with intestinal lymphoma. The number of Foxp3-positive intraepithelial cells was higher in dogs with small cell intestinal lymphoma. Some large cell intestinal lymphoma cases had high numbers of Foxp3-positive cells, but the increase was not statistically significant. Double-labeling immunofluorescence showed that CD3-positive granzyme B-negative helper T cells expressed Foxp3. In small cell intestinal lymphoma cases, the overall survival of dogs with a high Treg density was significantly worse than that of dogs with a normal Treg density. These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.
© The Author(s) 2015.

Entities:  

Keywords:  antitumor immunity; canine; chronic enteropathy; enteropathy-associated T-cell lymphoma; immunologic tolerance; regulatory T cell

Mesh:

Substances:

Year:  2015        PMID: 26173451     DOI: 10.1177/0300985815591081

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  17 in total

1.  Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma.

Authors:  K M Couto; P F Moore; A L Zwingenberger; J L Willcox; K A Skorupski
Journal:  Vet Comp Oncol       Date:  2018-01-11       Impact factor: 2.613

2.  Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma.

Authors:  Sita S Withers; Katherine A Skorupski; Daniel York; Jin W Choi; Kevin D Woolard; Renee Laufer-Amorim; Ellen E Sparger; Carlos O Rodriguez; Stephen J McSorley; Arta M Monjazeb; William J Murphy; Robert J Canter; Robert B Rebhun
Journal:  Vet Comp Oncol       Date:  2018-09-19       Impact factor: 2.613

3.  Serum levels of innate immunity cytokines are elevated in dogs with metaphyseal osteopathy (hypertrophic osteodytrophy) during active disease and remission.

Authors:  Noa Safra; Peta L Hitchens; Emanual Maverakis; Anupam Mitra; Courtney Korff; Eric Johnson; Amir Kol; Michael J Bannasch; Niels C Pedersen; Danika L Bannasch
Journal:  Vet Immunol Immunopathol       Date:  2016-08-03       Impact factor: 2.046

4.  TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice.

Authors:  Woo-Jin Song; Qiang Li; Min-Ok Ryu; Jin-Ok Ahn; Dong Ha Bhang; Yun Chan Jung; Hwa-Young Youn
Journal:  Stem Cell Res Ther       Date:  2018-04-06       Impact factor: 6.832

5.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

6.  Genome-wide association studies of inflammatory bowel disease in German shepherd dogs.

Authors:  Atiyeh Peiravan; Francesca Bertolini; Max F Rothschild; Kenneth W Simpson; Albert E Jergens; Karin Allenspach; Dirk Werling
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

7.  Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease.

Authors:  Maho Nakazawa; Shingo Maeda; Nozomu Yokoyama; Taisuke Nakagawa; Tomohiro Yonezawa; Koichi Ohno; Naoaki Matsuki
Journal:  J Vet Med Sci       Date:  2019-07-25       Impact factor: 1.267

8.  Fecal short-chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy.

Authors:  Yasushi Minamoto; Tomomi Minamoto; Anitha Isaiah; Panpicha Sattasathuchana; Agostino Buono; Venkat R Rangachari; Isaac H McNeely; Jonathan Lidbury; Jörg M Steiner; Jan S Suchodolski
Journal:  J Vet Intern Med       Date:  2019-05-17       Impact factor: 3.333

9.  Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma.

Authors:  Marie Omori; Shingo Maeda; Hirotaka Igarashi; Koichi Ohno; Kosei Sakai; Tomohiro Yonezawa; Ayako Horigome; Toshitaka Odamaki; Naoaki Matsuki
Journal:  J Vet Med Sci       Date:  2017-10-06       Impact factor: 1.267

Review 10.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.